News
Ansa on MSN5h
Italo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
HealthDay on MSN22h
FDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are among the most ...
Live Science on MSN6h
New brain implant can decode a person's 'inner monologue'
A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.
Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, ...
10h
Selonterra announces grant of United States patent on original discoveries in Alzheimer's disease
Selonterra, Inc. ( a biotechnology company developing transformative therapies for neurodegenerative disorders announces that ...
22h
Former Peterborough Pete, Toronto Maple Leaf Mark Kirton dies at 67 after seven-year battle with ALS
Mark Kirton was mortal, but his attitude was “super human”, says his former junior hockey coach. The Peterborough Petes and ...
Delays from the Food and Drug Administration continue to pile up, with Maryland-based Regenxbio the latest to report the review of one of its assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback